Thromboembolic Pulmonary Hypertension
📧 Sign up to get email alerts when something new happens for Thromboembolic Pulmonary Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH) [Phase 3]
Phase 3 trial assessing efficacy and tolerability of subcutaneously administered treprostinil sodium in patients with severe non-operable ch…
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH [Phase 2]
Phase 2 pilot study assessing the effect of riociguat on right ventricular function in chronic thromboembolic pulmonary hypertension has bee…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension [Phase 2]
Phase 2 study evaluating the efficacy, safety and tolerability of macitentan in inoperable chronic thromboembolic pulmonary hypertension has…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up
A completed clinical trial update on the NIMS implantable pump for pulmonary arterial hypertension, focusing on safety follow-up.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [Phase 3]
Phase 3 open-label study on long-term safety, tolerability, and efficacy of ambrisentan in inoperable chronic thromboembolic pulmonary hyper…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice
This completed study evaluated real-world treatment patterns in patients with pulmonary arterial hypertension or chronic thromboembolic pulm…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension [Phase 3]
Phase 3 clinical trial assessing how long-term oxygen therapy affects exercise capacity and quality of life in patients with pulmonary arter…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Pulmonary Perfusion Heterogeneity in Patients With CTEPH Using Functional PET Imaging
This clinical trial update reports on a completed study evaluating pulmonary perfusion heterogeneity in patients with chronic thromboembolic…
-
CLINICAL_TRIALS trial_result · 2016-08-12Clinical Trial Update: Effect of Short-term Oxygen During CPET in Pulmonary Hypertension [Phase 2]
A Phase 2 trial evaluating the effect of short-term oxygen during CPET in pulmonary hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension. [Phase 3]
Phase 3 trial of ambrisentan for inoperable chronic thromboembolic pulmonary hypertension was terminated. Results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients [NA]
Completed clinical trial evaluating lung-protective ventilation in patients undergoing pulmonary thromboendarterectomy for chronic thromboem…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. [Phase 3]
Phase 3 trial evaluating efficacy and safety of oral BAY63-2521 in patients with chronic thromboembolic pulmonary hypertension (CTEPH) has c…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Identification of Criteria of the Success of the Endarterectomy in Chronic Pulmonary Post Embolic Hypertension [NA]
Clinical trial update investigating criteria for successful endarterectomy in chronic thromboembolic pulmonary hypertension; study completed…
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [Phase 3]
Phase 3 study results update for bosentan in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH).